Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carmell Co. stock logo
CTCX
Carmell
$0.54
+3.3%
$0.53
$0.17
▼
$1.27
$11.27M0.514.65 million shs653 shs
Elutia Inc. stock logo
ELUT
Elutia
$0.81
-1.2%
$0.87
$0.50
▼
$1.39
$35.88M0.88135,291 shs5,640 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.41
-0.2%
$0.45
$0.22
▼
$0.60
$37.16M1.08833,973 shs37,503 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.65
-7.7%
$5.09
$3.92
▼
$40.87
$39.99M1.47117,002 shs68,807 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carmell Co. stock logo
CTCX
Carmell
0.00%0.00%0.00%0.00%-27.16%
Elutia Inc. stock logo
ELUT
Elutia
0.00%-3.55%-6.84%-14.29%-17.38%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
0.00%+0.79%-18.19%+28.22%-10.72%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%+10.77%+7.69%-48.83%-85.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carmell Co. stock logo
CTCX
Carmell
$0.54
+3.3%
$0.53
$0.17
▼
$1.27
$11.27M0.514.65 million shs653 shs
Elutia Inc. stock logo
ELUT
Elutia
$0.81
-1.2%
$0.87
$0.50
▼
$1.39
$35.88M0.88135,291 shs5,640 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.41
-0.2%
$0.45
$0.22
▼
$0.60
$37.16M1.08833,973 shs37,503 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.65
-7.7%
$5.09
$3.92
▼
$40.87
$39.99M1.47117,002 shs68,807 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carmell Co. stock logo
CTCX
Carmell
0.00%0.00%0.00%0.00%-27.16%
Elutia Inc. stock logo
ELUT
Elutia
0.00%-3.55%-6.84%-14.29%-17.38%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
0.00%+0.79%-18.19%+28.22%-10.72%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%+10.77%+7.69%-48.83%-85.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carmell Co. stock logo
CTCX
Carmell
0.00
N/AN/AN/A
Elutia Inc. stock logo
ELUT
Elutia
1.00
SellN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.00140.38% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
1.67
Reduce$47.00915.12% Upside

Current Analyst Ratings Breakdown

Latest CTCX, SNWV, MLSS, and ELUT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeHold (C-) ➝ Sell (D+)
8/27/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeHold (C) ➝ Hold (C-)
8/18/2026
Elutia Inc. stock logo
ELUT
Elutia
DowngradeSell (D+) ➝ Sell (D)
8/17/2026
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
Set Price Target$1.00
8/17/2026
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
Reiterated RatingSpeculative Buy
8/11/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
UpgradeHold (C-) ➝ Hold (C)
7/23/2026
Elutia Inc. stock logo
ELUT
Elutia
DowngradeHold (C-) ➝ Sell (D+)
7/7/2026
Elutia Inc. stock logo
ELUT
Elutia
UpgradeSell (D+) ➝ Hold (C-)
(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carmell Co. stock logo
CTCX
Carmell
$32.84K343.12N/AN/A$1.07 per share0.50
Elutia Inc. stock logo
ELUT
Elutia
$12.29M2.92N/AN/A$0.65 per share1.25
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$9.42M4.00N/AN/A$0.11 per share3.78
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$44.05M0.90$1.56 per share2.97$0.19 per share24.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carmell Co. stock logo
CTCX
Carmell
-$15.44M-$0.46N/AN/AN/AN/A-217.50%-50.22%N/A
Elutia Inc. stock logo
ELUT
Elutia
$53.38M$0.950.85N/AN/A426.93%-407.37%-47.08%11/12/2026 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.04N/AN/AN/A-52.01%-60.26%-40.23%N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$11.81M$0.2419.29N/AN/A32.38%1,728.10%39.04%11/6/2026 (Estimated)

Latest CTCX, SNWV, MLSS, and ELUT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Elutia Inc. stock logo
ELUT
Elutia
-$0.15-$0.17-$0.02-$0.17$2.90 million$2.43 million
8/6/2026Q2 2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.03-$0.08-$0.05-$0.08$11.50 million$9.74 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/A
Elutia Inc. stock logo
ELUT
Elutia
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carmell Co. stock logo
CTCX
Carmell
N/A
0.31
0.29
Elutia Inc. stock logo
ELUT
Elutia
N/A
1.77
1.64
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
4.87
1.28
0.89

Institutional Ownership

CompanyInstitutional Ownership
Carmell Co. stock logo
CTCX
Carmell
24.22%
Elutia Inc. stock logo
ELUT
Elutia
74.03%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%

Insider Ownership

CompanyInsider Ownership
Carmell Co. stock logo
CTCX
Carmell
29.00%
Elutia Inc. stock logo
ELUT
Elutia
17.80%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
9.22%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carmell Co. stock logo
CTCX
Carmell
1420.91 million14.84 millionNot Optionable
Elutia Inc. stock logo
ELUT
Elutia
18044.29 million36.41 millionNot Optionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
1590.64 million58.61 millionOptionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
558.60 million7.36 millionN/A

Recent News About These Companies

Comparing Sanuwave Health (NASDAQ:SNWV) and Nano-X Imaging (NASDAQ:NNOX)
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Health Updates Second Quarter 2026 Guidance

Media Sentiment Over Time

Carmell stock logo

Carmell NASDAQ:CTCX

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Elutia stock logo

Elutia NASDAQ:ELUT

$0.81 -0.01 (-1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$0.82 +0.01 (+0.74%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.41 0.00 (-0.17%)
Closing price 04:00 PM Eastern
Extended Trading
$0.42 +0.01 (+1.71%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$4.65 -0.39 (-7.74%)
Closing price 04:00 PM Eastern
Extended Trading
$4.63 -0.02 (-0.43%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.